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Introduction
Endometriosis is a comon, benign, inflamatory, pathology, represented by the ectopic
location of functional endometrial glands and stroma outside the uterine cavity [1, 2].
Matrix metalloproteinase (MMP) represents a large family zinc-dependent
endopeptidases, involved in the degradation of the extracellular matrix in the process of
endometrial cell implantation and are classified by their substrate specificity [7, 8].
Matrix metalloproteinases (MMPs) are essential in orchestrating proper physiological
functioning of the endometrium; hence, alteration of MMP activities is considered as a
critical factor for the development of endometriosis. MMPs are involved in the cellular
event of epithelial-mesenchymal transition [10, 22].
Purpose
The aim of this study was to evaluate the immunohistochemical expression of matrix-
metalloproteinases MMP1, MMP2, MMP9 and MMP14 in surgical excision specimens,
collected from women with extragenital endometriosis compared to their expression in
the normal endometrium.
Results
The classical histopatological examination of the general expression of MMP-1, MMP-2,
MMP-9 and MMP-14 revealed a diverse variability. For MMP-2, MMP-9, MMP-14 markers,
the reaction positivity was variable not only from one case to another but also within each
case, the latter being characterized by the identification of different areas within
endometriosis.
Conclusions
The MMP-9 and MMP-14 activity significant elevation, established on ectopic endometrium
of women with endometriosis. Study of MMP-1, MMP-2, MMP-9 and MMP-14 activities in
endometriotic lesions from women with endometriosis is perspective for further
investigation in order to determine a possible role of matrix metalloproteinases in the
development of invasiviness process in case of extragenital endometriosis.
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MMP-1 Mouse monoclonal 6A5 Acris AM06648SU-N 1:200
0.1 M Citrate, 
pH 6
Granulation tissue
MMP-2 Mouse monoclonal OTI4A11 OriGene TA806846 1:100
1mM EDTA in 10mM 
Tris buffer (pH8.5)
Granulation tissue
MMP-9 Mouse monoclonal 5G3 OriGene AM06662SU-N 1:200
0.1 M Citrate, 
pH 6
Granulation tissue 
MMP-14 Mouse monoclonal 113-5B7 OriGene AF8410 1:100 0.1 M Citrate, pH6 Granulation tissue
Antibodies used in immunohistochemical study
Table 1
Material and methods
The patient group consist 42 women with endometriosis, age range of 21-63 years (median
40), diagnosed and surgically treated at Department of Surgery, Obstetrics and Gynecology
from Gherghe Paladi Municipal Clinical Hospital, Sfantul Arhanghel Mihail Municipal
Clinical Hospital, Chisinau, the Republic of Moldova and Emergency County Hospital,
Craiova, Romania. Location included: the anterior abdominal wall after caesarean operation
– 20, inguinal hernia – 7, umbilical hernia – 4, perineal region – 1, appendix – 4, colon – 5,
and ileum – 1case.
Fig. 1. Immunohistochemical reaction interpretation, A, C, E, G – endometriosis and B, D, F, H – normal endometrium.
Neagative reaction for MMP-1 in (A, B), moderate positive reaction for MMP-2 in (C, D), strong positive reaction for MMP-9 and MMP-14 in (E, F, G, H). IHC, obiective 10 ×
/0.30.
Immunohistochemical analysis has demonstrated the significant enhance of MMP-9 and MMP-
14 expressions in endometriosis and in endometrium. The distinctive feature of MMP-9 and
MMP-14 expression in endometriosis was considerable increase of its activity precisely on the
border of endometriotic lesion and the peritoneum.
